Published in J Radiat Res on May 09, 2013
Toxicity and efficacy of three dose-fractionation regimens of intensity-modulated radiation therapy for localized prostate cancer. J Radiat Res (2013) 0.86
In vivo measurement of dose distribution in patients' lymphocytes: helical tomotherapy versus step-and-shoot IMRT in prostate cancer. J Radiat Res (2014) 0.78
Longitudinal change in health-related quality of life after intensity-modulated radiation monotherapy for clinically localized prostate cancer. Qual Life Res (2013) 0.75
Dose-volume histogram comparison between static 5-field IMRT with 18-MV X-rays and helical tomotherapy with 6-MV X-rays. J Radiat Res (2015) 0.75
Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys (1995) 15.12
Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology (2000) 6.42
Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst (2004) 5.84
Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol (1998) 4.94
The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care (1998) 4.34
High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys (2002) 2.65
Advances in image-guided radiation therapy. J Clin Oncol (2007) 2.47
Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment. J Clin Oncol (2010) 2.42
Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function. J Clin Oncol (2009) 2.40
The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer. Cancer (2008) 1.98
Health-related quality of life after radical retropubic prostatectomy and permanent prostate brachytherapy: a 3-year follow-up study. Int J Urol (2011) 1.46
Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era. J Urol (2001) 1.27
Urinary and sexual outcomes in long-term (5+ years) prostate cancer disease free survivors after radical prostatectomy. Health Qual Life Outcomes (2009) 1.07
Five-year follow-up of health-related quality of life after intensity-modulated radiation therapy for prostate cancer. Jpn J Clin Oncol (2009) 1.05
Health-related quality of life 3 years after high-dose intensity-modulated radiotherapy with gold fiducial marker-based position verification. BJU Int (2008) 0.95
No impairment of quality of life 18 months after high-dose intensity-modulated radiotherapy for localized prostate cancer: a prospective study. Int J Radiat Oncol Biol Phys (2009) 0.93
Quality of life after radical prostatectomy in Japanese men: a 5-Year follow up study. Int J Urol (2008) 0.89
Use of implanted markers and interportal adjustment with real-time tracking radiotherapy system to reduce intrafraction prostate motion. Int J Radiat Oncol Biol Phys (2011) 0.86
Analysis linking UCLA PCI with Expanded Prostate Cancer Index Composite: an evaluation of health related quality of life in Japanese men with localized prostate cancer. J Urol (2007) 0.85
Psychological distress in cancer patients undergoing radiation therapy treatment. Support Care Cancer (2012) 0.82
Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA (2010) 5.04
Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer (2004) 4.54
Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. Int J Radiat Oncol Biol Phys (2002) 4.24
Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol (2007) 3.91
Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys (2010) 3.66
Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys (2007) 2.56
The management of imaging dose during image-guided radiotherapy: report of the AAPM Task Group 75. Med Phys (2007) 2.42
Survival and prognostic classification of patients with metastatic renal cell carcinoma of bone. Eur Urol (2006) 2.34
Inhibition of mTORC2 but not mTORC1 up-regulates E-cadherin expression and inhibits cell motility by blocking HIF-2α expression in human renal cell carcinoma. J Urol (2012) 2.08
Differences in CT perfusion maps generated by different commercial software: quantitative analysis by using identical source data of acute stroke patients. Radiology (2010) 2.03
Dosimetric comparison between intensity-modulated radiotherapy and standard wedged tangential technique for whole-breast radiotherapy in Asian women with relatively small breast volumes. Radiol Phys Technol (2013) 2.02
Abnormal dimercapto-succinic acid scan is a predictive factor of breakthrough urinary tract infection in children with primary vesicoureteral reflux. J Urol (2009) 2.01
Current use of the artificial urinary sphincter and its long-term durability: a nationwide survey in Japan. Int J Urol (2009) 1.96
Efficacy of intense screening and treatment for synchronous second primary cancers in patients with esophageal cancer. Jpn J Clin Oncol (2002) 1.85
Induction chemotherapy followed by low-dose involved-field radiotherapy for intracranial germ cell tumors. J Clin Oncol (2002) 1.81
Impact of multimodal treatment on survival in patients with metastatic urothelial cancer. Eur Urol (2007) 1.77
Prediction of respiratory tumour motion for real-time image-guided radiotherapy. Phys Med Biol (2004) 1.66
Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys (2003) 1.63
Three-dimensional intrafractional movement of prostate measured during real-time tumor-tracking radiotherapy in supine and prone treatment positions. Int J Radiat Oncol Biol Phys (2002) 1.63
Synchronized moving aperture radiation therapy (SMART): average tumour trajectory for lung patients. Phys Med Biol (2003) 1.61
Accuracy of tumor motion compensation algorithm from a robotic respiratory tracking system: a simulation study. Med Phys (2007) 1.56
Splenic volume measurements on computed tomography utilizing automatically contouring software and its relationship with age, gender, and anthropometric parameters. Eur J Radiol (2009) 1.56
Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial. Hypertension (2008) 1.54
Residual motion of lung tumours in gated radiotherapy with external respiratory surrogates. Phys Med Biol (2005) 1.54
The role of lymph-node dissection in the treatment of upper urinary tract cancer: a multi-institutional study. BJU Int (2008) 1.53
Acute hemodynamic effects of adaptive servo-ventilation in patients with heart failure. Circ J (2013) 1.53
Characteristics of patients who developed radiation pneumonitis requiring steroid therapy after stereotactic irradiation for lung tumors. Cancer J (2006) 1.52
Calculation of rotational setup error using the real-time tracking radiation therapy (RTRT) system and its application to the treatment of spinal schwannoma. Int J Radiat Oncol Biol Phys (2002) 1.52
Cytogenetic abnormalities of tumor-associated endothelial cells in human malignant tumors. Am J Pathol (2009) 1.51
Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.49
Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer (2013) 1.49
Internal-external correlation investigations of respiratory induced motion of lung tumors. Med Phys (2007) 1.48
Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial. Hypertens Res (2010) 1.47
Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group. Int J Radiat Oncol Biol Phys (2009) 1.47
Lower aerobic capacity was associated with abnormal intramuscular energetics in patients with metabolic syndrome. Hypertens Res (2011) 1.47
RENAL nephrometry score is a predictive factor for the annual growth rate of renal mass. Int J Urol (2014) 1.43
Influence of baseline renal function and dose reduction of nephrotoxic chemotherapeutic agents on the outcome of metastatic urothelial carcinoma: a retrospective study. Int J Urol (2011) 1.42
Effects of cardiac complications on cardiovascular events in Japanese high-risk hypertensive patients: subanalysis of the CASE-J trial. Circ J (2009) 1.40
Long-term outcome of vaginoplasty with the bilateral labioscrotal flap. J Urol (2009) 1.40
Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy. Cancer Res (2010) 1.39
Spinal cord gliomas: A multi-institutional retrospective analysis. Int J Radiat Oncol Biol Phys (2005) 1.37
Intrafractional tumor motion: lung and liver. Semin Radiat Oncol (2004) 1.37
Integrated radiotherapy imaging system (IRIS): design considerations of tumour tracking with linac gantry-mounted diagnostic x-ray systems with flat-panel detectors. Phys Med Biol (2004) 1.32
Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy. Radiother Oncol (2009) 1.29
Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis. J Natl Cancer Inst (2013) 1.28
A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma. Cancer (2002) 1.26
Management of renal angiomyolipomas associated with tuberous sclerosis complex. J Urol (2004) 1.25
Medical management of recurrent aggressive angiomyxoma with gonadotropin-releasing hormone agonist. Int J Urol (2004) 1.25
Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull. Int J Radiat Oncol Biol Phys (2003) 1.24
Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis. Eur J Cancer (2013) 1.24
Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. Int J Radiat Oncol Biol Phys (2002) 1.23
Difference in tracer delay-induced effect among deconvolution algorithms in CT perfusion analysis: quantitative evaluation with digital phantoms. Radiology (2009) 1.22
Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions. Jpn J Clin Oncol (2010) 1.18
Tumor location, cirrhosis, and surgical history contribute to tumor movement in the liver, as measured during stereotactic irradiation using a real-time tumor-tracking radiotherapy system. Int J Radiat Oncol Biol Phys (2003) 1.13
Rab5c promotes AMAP1-PRKD2 complex formation to enhance β1 integrin recycling in EGF-induced cancer invasion. J Cell Biol (2012) 1.12
Accuracy and reliability assessment of CT and MR perfusion analysis software using a digital phantom. Radiology (2012) 1.11
Heterogeneity of tumor endothelial cells: comparison between tumor endothelial cells isolated from high- and low-metastatic tumors. Am J Pathol (2012) 1.11
High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer. J Nucl Med (2013) 1.11
Direct targeting of fibroblast growth factor-inducible 14 protein protects against renal ischemia reperfusion injury. Kidney Int (2010) 1.11
A new PET scanner with semiconductor detectors enables better identification of intratumoral inhomogeneity. J Nucl Med (2008) 1.11
Real-time monitoring of a digestive tract marker to reduce adverse effects of moving organs at risk (OAR) in radiotherapy for thoracic and abdominal tumors. Int J Radiat Oncol Biol Phys (2005) 1.10
Cohort profile: the Hokkaido study on environment and children's health in Japan. Int J Epidemiol (2010) 1.10
Dosimetric verification in participating institutions in a stereotactic body radiotherapy trial for stage I non-small cell lung cancer: Japan clinical oncology group trial (JCOG0403). Phys Med Biol (2006) 1.10
Stereotactic radiotherapy for intracranial nonacoustic schwannomas including facial nerve schwannoma. Int J Radiat Oncol Biol Phys (2009) 1.09
Registration accuracy and possible migration of internal fiducial gold marker implanted in prostate and liver treated with real-time tumor-tracking radiation therapy (RTRT). Radiother Oncol (2002) 1.08
Insertion and fixation of fiducial markers for setup and tracking of lung tumors in radiotherapy. Int J Radiat Oncol Biol Phys (2005) 1.08
Left paraduodenal hernia successfully treated with laparoscopic surgery: a case report. Case Rep Gastroenterol (2007) 1.07
The effect of tumor location and respiratory function on tumor movement estimated by real-time tracking radiotherapy (RTRT) system. Int J Radiat Oncol Biol Phys (2005) 1.07
Real-time 4-D radiotherapy for lung cancer. Cancer Sci (2011) 1.07
Exophytic giant cavernous hemangioma of the liver with growing tendency. Radiat Med (2005) 1.06
Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma. Neuro Oncol (2013) 1.06
Concomitant weekly cisplatin and radiotherapy for head and neck cancer. Jpn J Clin Oncol (2011) 1.04
Postoperative inguinal hernia after radical prostatectomy for prostate cancer. Urology (2007) 1.04
The optimal target blood pressure for antihypertensive treatment in Japanese elderly patients with high-risk hypertension: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial. Hypertens Res (2008) 1.03
Adaptive prediction of respiratory motion for motion compensation radiotherapy. Phys Med Biol (2007) 1.03
CXCR7: a novel tumor endothelial marker in renal cell carcinoma. Pathol Int (2012) 1.03
Patterns of drug use and HIV-related risk behaviors among incarcerated people in a prison in Iran. J Urban Health (2010) 1.02
Three-dimensional intrafractional motion of breast during tangential breast irradiation monitored with high-sampling frequency using a real-time tumor-tracking radiotherapy system. Int J Radiat Oncol Biol Phys (2007) 1.02